Epi-cochlioquinone A, a novel acyl-CoA:cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi

被引:29
作者
Fujioka, T
Yao, K
Hamano, K
Hosoya, T
Kagasaki, T
Furukawa, Y
Haruyama, H
Sato, S
Koga, T
Tsujita, Y
机构
[1] SANKYO CO LTD,RES INST,BIOMED RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[2] SANKYO CO LTD,RES INST,ANALYT & METAB RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[3] SANKYO CO LTD,TSUKUBA RES LABS,TSUKUBA,IBARAKI 305,JAPAN
[4] SCI INFORMAT CO LTD,SHINAGAWA KU,TOKYO 140,JAPAN
关键词
D O I
10.7164/antibiotics.49.409
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A novel acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, designated epi-cochlioquinone A has been isolated from the fermentation broth of Stachybotrys bisbyi SANK 17777. The molecular formula, physicochemical properties, NMR spectroscopic analysis and X-ray crystallographic analysis revealed that this compound was a stereoisomer of cochlioquinone A, which has been previously reported as a nematocidal agent. It inhibited ACAT activity in an enzyme assay using rat liver microsomes with an IC50 value of 1.7 mu M. However, it showed about 10-fold less potent inhibitory effect on plasma lecithin cholesterol acyltransferase (LCAT) than on ACAT. In addition, it inhibited in vivo cholesterol absorption in rats by 50% at 75 mg/kg.
引用
收藏
页码:409 / 413
页数:5
相关论文
共 12 条
[1]  
[Anonymous], 1974, INT TABLES XRAY CRYS, VIV
[2]  
CANONICA L, 1976, GAZZ CHIM ITAL, V106, P147
[3]   STRUCTURES OF COCHLIOQUINONES-A AND B, NEW METABOLITES OF COCHLIOBOLUS-MIYABEANUS - CHEMICAL AND X-RAY CRYSTALLOGRAPHIC DETERMINATION [J].
CARRUTHE.JR ;
CERRINI, S ;
FEDELI, W ;
CASINOVI, CG ;
GALEFFI, C ;
VACCARO, AMT ;
SCALA, A .
JOURNAL OF THE CHEMICAL SOCIETY D-CHEMICAL COMMUNICATIONS, 1971, (03) :164-&
[4]  
GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241
[5]  
GROMSET JA, 1968, J LIPID RES, V9, P155
[6]  
Hatch F T, 1968, Adv Lipid Res, V6, P1
[7]  
JONG S C, 1976, Mycotaxon, V3, P409
[8]  
MAIN P, 1978, MULTAN SYSTEM COMPUT
[9]   COCHLIOQUINONE-A, A NEMATOCIDAL AGENT WHICH COMPETES FOR SPECIFIC [H-3] IVERMECTIN BINDING-SITES [J].
SCHAEFFER, JM ;
FRAZIER, EG ;
BERGSTROM, AR ;
WILLIAMSON, JM ;
LIESCH, JM ;
GOETZ, MA .
JOURNAL OF ANTIBIOTICS, 1990, 43 (09) :1179-1182
[10]  
STAHLBERG D, 1989, J LIPID RES, V30, P953